Platform
Features
0 followers
Our scientific initial efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow using an LSD1 inhibitor
Industries
Headquarters
Stage
Employees
Links
Hugh Y. Rienhoff, Jr.
15 members
9 members
5 members
4 members
3 members
Kura Oncology
17 followers
Genesis Therapeutics
1 follower
Allakos
PathAI
55 followers
Bolt Biotherapeutics
5 followers
Discover companies